October 12, 2023 | 12:00 PM - 1:00 PM ET


The world of biosimilar litigation is back in full swing with several BPCIA lawsuits currently pending. This webinar covers strategies and considerations during pre-litigation disclosures under the BPCIA (the so-called "patent dance") and in BPCIA litigation with a particular focus on what we have learned from the most recent wave of BPCIA litigations. We will discuss considerations for the timing of filing an aBLA, strategies for disclosure during the patent dance and early litigation, and key issues during BPCIA litigation from a reference product sponsor and biosimilar applicant perspective.

Elaine Blais, Natasha Daughtrey and Alexandra Valenti will host this webinar.

CLE credit will be offered for California, Minnesota, New Jersey, New York and Pennsylvania.